In this file
A syringe marking and an amount of active medicine describe different things. With a compounded vial, the concentration determines how a measured volume relates to the medicine prescribed.
That is why a number someone posts online cannot safely become another patient’s instruction. FDA has reported dosing errors involving compounded injectable semaglutide, including errors linked to measurement and conversion confusion.
Two different measurements
Milligrams express an amount of a substance. Milliliters express a volume of liquid. Syringe markings can represent a volume scale, and their interpretation depends on the device. None of those measurements can be substituted for another without the correct product information.
The pharmacy’s concentration connects the medicine amount to the liquid volume. If that concentration changes, an old syringe marking can correspond to a different amount of medicine. This article intentionally does not supply a universal conversion table.
Why a refill needs attention
A new vial may have a different concentration, total volume, additional ingredients, or pharmacy instructions. The online provider’s brand can remain the same while the dispensed preparation changes.
Before using a refill, compare its label with the prescriber’s current directions and ask about any difference. Do not assume a familiar vial size or similar packaging makes the instructions identical.
What to ask the pharmacist
Have the actual label and the supplied syringe available. Ask the pharmacist to confirm the prescribed medicine amount, the correct measurement for that concentration, the device to use, and the storage and beyond-use information.
Repeat the explanation in your own words and ask for written clarification if the label or portal says something different. A support agent locating an order is not a substitute for a professional resolving conflicting medication directions.
If you think an error occurred
Contact the prescribing professional promptly if you may have taken an incorrect amount. If symptoms are severe, you feel seriously unwell, or there is an immediate safety concern, seek urgent medical help rather than waiting for a routine portal reply.
Keep the packaging and instructions available for the professional assisting you. Do not attempt to compensate for a suspected error by improvising another amount or changing the schedule yourself.
A safer transfer conversation
When moving providers, share the current label and treatment record with the receiving clinician. Ask the new pharmacy for directions tied to the new product, even if the active ingredient name stays the same.
The care-transfer comparison explains the records and payment questions involved. Clinical instructions must come from the professionals responsible for the prescription.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- FDA: compounded semaglutide dosing errors ↗Regulatory / public agency · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- MedlinePlus: semaglutide injection ↗Medical reference · Checked September 22, 2026